These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17047616)

  • 1. [Effect of Lorazepam on emotional status and quality of life of patients with ischemic heart disease].
    Ibatov AD
    Kardiologiia; 2006; 46(9):11-4. PubMed ID: 17047616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The course of coronary heart disease and quality of life in patients with anxiety of different degree].
    Ibatov AD
    Ter Arkh; 2007; 79(12):35-8. PubMed ID: 18220028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spectrum of therapeutic efficacy and safety of Lorafen (lorazepam) use for anxiety disorders].
    Ivanov SV; Il'ina NA; Burlakov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(8):38-41. PubMed ID: 14564776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
    Woelk H; Schläfke S
    Phytomedicine; 2010 Feb; 17(2):94-9. PubMed ID: 19962288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
    Finkel S
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clorazepate and lorazepam: clinical improvement and rebound anxiety.
    Rickels K; Fox IL; Greenblatt DJ; Sandler KR; Schless A
    Am J Psychiatry; 1988 Mar; 145(3):312-7. PubMed ID: 2894175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical assessment of lorazepam in anxiety: a double-blind study.
    Olgiati SG
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):13-22. PubMed ID: 237741
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Morales-Valdéz M; García-Valencia CE; Tortoriello J
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effectiveness of Galphimia glauca vs. lorazepam in generalized anxiety disorder. A controlled 15-week clinical trial.
    Herrera-Arellano A; Jiménez-Ferrer JE; Zamilpa A; García-Alonso G; Herrera-Alvarez S; Tortoriello J
    Planta Med; 2012 Sep; 78(14):1529-35. PubMed ID: 22828921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lorazepam in the treatment of neurosis.
    Lameiras JC
    Curr Med Res Opin; 1976; 4(6):441-5. PubMed ID: 11961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
    Zung WW; Daniel JT; King RE; Moore DT
    J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety therapy in the neoplastic patient.
    Battelli T; Bonsignori M; Manocchi P; Rossi G
    Curr Med Res Opin; 1976; 4(3):185-8. PubMed ID: 7432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lorazepam does not improve the quality of recovery in day-case surgery patients: a randomised placebo-controlled clinical trial.
    Mijderwijk H; van Beek S; Klimek M; Duivenvoorden HJ; Grüne F; Stolker RJ
    Eur J Anaesthesiol; 2013 Dec; 30(12):743-51. PubMed ID: 23635914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autonomic regulation and emotional status in patients with ischemic heart disease having pain syndrome of various severity].
    Ibatov AD; Syrkin AL; Veĭn AM; Syrkina EA; Baevskiĭ RM; Ibatova OV
    Klin Med (Mosk); 2003; 81(12):36-40. PubMed ID: 14971155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile of lorazepam, a new benzodiazepine tranquilizer.
    Richards DJ
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):58-66. PubMed ID: 30770
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology.
    McCurdy L; Schatzberg AF
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):30-4. PubMed ID: 30765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.